Quach H - Search Results

1

Myeloma natural killer cells are exhausted and have impaired regulation of activation.

D'Souza C, Keam SP, Yeang HXA, Neeson M, Richardson K, Hsu AK, Canfield R, Bezman N, Robbins M, Quach H, Ritchie DS, Harrison SJ, Trapani JA, Prince HM, Beavis PA, Darcy PK, Neeson PJ. D'Souza C, et al. Among authors: quach h. Haematologica. 2021 Sep 1;106(9):2522-2526. doi: 10.3324/haematol.2020.277525. Haematologica. 2021. PMID: 34011135 Free PMC article. No abstract available.

2

Effective treatment of leptomeningeal multiple myeloma with total craniospinal irradiation supported by second allogeneic donor stem cell infusion.

Quach H, Ryan G, Ganju V, Prince HM. Quach H, et al. Bone Marrow Transplant. 2005 Feb;35(4):423-4. doi: 10.1038/sj.bmt.1704777. Bone Marrow Transplant. 2005. PMID: 15608656 No abstract available.

3

Treatment strategies in elderly patients with multiple myeloma: current status.

Quach H, Prince HM, Mileshkin L. Quach H, et al. Drugs Aging. 2007;24(10):829-50. doi: 10.2165/00002512-200724100-00004. Drugs Aging. 2007. PMID: 17896832 Review.

4

In vivo tracking of dendritic cells in patients with multiple myeloma.

Prince HM, Wall DM, Ritchie D, Honemann D, Harrrison S, Quach H, Thompson M, Hicks R, Lau E, Davison J, Loudovaris M, Moloney J, Loveland B, Bartholeyns J, Katsifis A, Mileshkin L. Prince HM, et al. Among authors: quach h. J Immunother. 2008 Feb-Mar;31(2):166-79. doi: 10.1097/CJI.0b013e31815c5153. J Immunother. 2008. PMID: 18481386

5

Predicting durable remissions following thalidomide therapy for relapsed myeloma.

Quach H, Mileshkin L, Seymour JF, Milner A, Ritchie D, Harrison S, Westerman D, Prince HM. Quach H, et al. Leuk Lymphoma. 2009 Feb;50(2):223-9. doi: 10.1080/10428190802663213. Leuk Lymphoma. 2009. PMID: 19194832 Clinical Trial.

6

Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patients.

Quach H, Horvath N, Cannell P, Mikhael JR, Butcher BE, Prince HM. Quach H, et al. Intern Med J. 2009 May;39(5):290-5. doi: 10.1111/j.1445-5994.2008.01738.x. Epub 2008 Jun 28. Intern Med J. 2009. PMID: 19371392

7

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Quach H, Ritchie D, Stewart AK, Neeson P, Harrison S, Smyth MJ, Prince HM. Quach H, et al. Leukemia. 2010 Jan;24(1):22-32. doi: 10.1038/leu.2009.236. Epub 2009 Nov 12. Leukemia. 2010. PMID: 19907437 Free PMC article. Review.

8

Testing the NKT cell hypothesis in lenalidomide-treated myelodysplastic syndrome patients.

Chan AC, Neeson P, Leeansyah E, Tainton K, Quach H, Prince HM, Godfrey DI, Ritchie D, Berzins SP. Chan AC, et al. Among authors: quach h. Leukemia. 2010 Mar;24(3):592-600. doi: 10.1038/leu.2009.279. Epub 2010 Jan 14. Leukemia. 2010. PMID: 20072154

9

Extra-nasal NK/T cell lymphoma masquerading as renal infarction.

Sem Liew M, Chan AM, Galloway S, Comin G, Flaim B, Prince HM, Quach H. Sem Liew M, et al. Among authors: quach h. Leuk Lymphoma. 2010 Jun;51(6):1139-41. doi: 10.3109/10428191003777971. Leuk Lymphoma. 2010. PMID: 20370540 No abstract available.

10

Drug-mediated and cellular immunotherapy in multiple myeloma.

Ritchie DS, Quach H, Fielding K, Neeson P. Ritchie DS, et al. Among authors: quach h. Immunotherapy. 2010 Mar;2(2):243-55. doi: 10.2217/imt.10.9. Immunotherapy. 2010. PMID: 20635931 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters